ImmuPharma plc
IMM.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £397 | £397 | £237 | £237 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £155 | £155 | £429 | £0 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £949 | £949 | £219 | £648 |
| Total Curr. Assets | £1,501 | £1,501 | £885 | £885 |
| Property Plant & Equip (Net) | £74 | £74 | £82 | £82 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £5 | £5 | £10 | £10 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £79 | £79 | £92 | £92 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1,581 | £1,581 | £977 | £977 |
| Liabilities | – | – | – | – |
| Payables | £1,244 | £1,244 | £511 | £511 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £118 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £0 | £0 | £891 | £1,009 |
| Total Curr. Liab. | £1,244 | £1,244 | £1,520 | £1,520 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £1,244 | £1,244 | £1,520 | £1,520 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £30,646 | £30,646 | £29,813 | £29,813 |
| Retained Earnings | -£67,750 | -£67,750 | -£65,911 | -£65,911 |
| AOCI | £6,258 | £6,258 | £6,238 | £6,238 |
| Other Equity | £31,183 | £31,183 | £29,317 | £29,317 |
| Total Equity | £337 | £337 | -£543 | -£543 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1,581 | £1,581 | £977 | £977 |
| Net Debt | -£397 | -£397 | -£237 | -£237 |